Abstract
Purpose
We retrospectively investigated the impact of race/ethnicity on prognosis in patients who underwent surgery for colon cancer.
Methods
Surveillance, Epidemiology, and End Results population-based data on 39,210 colon cancer patients without distant metastasis who underwent radical surgery were analyzed. Prognostic impact of race/ethnicity for non-Hispanic white, Hispanic white, African American, and East Asian (Japanese, Chinese, Korean) American patients, and confounding factors of age, sex, registry region, year of diagnosis, tumor, node, metastasis system stage, tumor grade, tumor site, and the number of lymph nodes examined were analyzed by the Cox proportional hazard model. The lymph node count was analyzed and adjusted means were calculated by a generalized multiple regression model with respect to race and other factors.
Results
Significant differences due to race/ethnicity were observed in crude hazard ratios with respect to overall and colon cancer-specific mortality, which persisted even after adjusting for confounding factors. Adjusted hazard ratios of colon cancer-specific mortality for non-Hispanic white, Hispanic white, African American, and East Asian American patients were 1 (reference), 1.01 (95% confidence interval 0.91–1.12), 1.40 (95% confidence interval 1.31–1.50), and 0.83 (95% confidence interval 0.74–0.94), respectively. There were significant differences in crude number of lymph nodes examined among races, which were no longer significant after adjusting for covariates.
Conclusions
East Asian American patients had significantly better prognosis, while African American patients had worse prognosis than non-Hispanic white patients, despite the identical adjusted number of lymph nodes examined after surgery for colon cancer. This disparity in prognosis among races/ethnicities should be taken into consideration when deciding adjuvant chemotherapy for nonwhite patients.
Similar content being viewed by others
References
Alexander DD, Waterbor J, Hughes T, Funkhouser E, Grizzle W, Manne U. African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review. Cancer Biomark. 2007;3:301–13.
Wudel LJ Jr, Chapman WC, Shyr Y, et al. Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival. Arch Surg. 2002;137:550–4.
Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med. 2002;162:1985–93.
Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007;14:3328–34.
Watanabe T. Ongoing colorectal cancer adjuvant trials in Japan. Curr Colorectal Cancer Rep. 2010;6:168–74.
Farrow DC, Samet JM, Hunt WC. Regional variation in survival following the diagnosis of cancer. J Clin Epidemiol. 1996;49:843–7.
Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9:730–56.
Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99:433–41.
Bilimoria KY, Bentrem DJ, Stewart AK, et al. Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst. 2008;100:1310–17.
Chou JF, Row D, Gonen M, Liu YH, Schrag D, Weiser MR. Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study. Cancer. 2010;116:2560–70.
Surveillance, Epidemiology, and End Results (SEER) Program Limited-Use Data (1973–2006). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2007 submission. http://www.seer.cancer.gov.
Sobin L, Gospodarowicz M, Wittekind C. International Union Against Cancer (UICC). TNM classification of malignant tumours. 7th ed. Oxford: Wiley; 2010.
Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78–93.
Freeman HP. Commentary on the meaning of race in science and society. Cancer Epidemiol Biomarkers Prev. 2003;12:232s–6s.
Le H, Ziogas A, Lipkin SM, Zell JA. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev. 2008;17:1950–62.
White A, Vernon SW, Franzini L, Du XL. Racial disparities in colorectal cancer survival: to what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics? Cancer. 2010;116:4622–31.
Lin SS, Clarke CA, Prehn AW, Glaser SL, West DW, O’Malley CD. Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas. Cancer. 2002;94:1175–82.
McCracken M, Olsen M, Chen MS Jr, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin. 2007;57:190–205.
Hashiguchi Y, Hase K, Ueno H, et al. Prognostic significance of the number of lymph nodes examined in colon cancer surgery: clinical application beyond simple measurement. Ann Surg. 2010;251:872–81.
Gomez SL, Le GM, West DW, Satariano WA, O’Connor L. Hospital policy and practice regarding the collection of data on race, ethnicity, and birthplace. Am J Public Health. 2003;93:1685–8.
Stewart SL, Swallen KC, Glaser SL, Horn-Ross PL, West DW. Adjustment of cancer incidence rates for ethnic misclassification. Biometrics. 1998;54:774–81.
Stewart SL, Swallen KC, Glaser SL, Horn-Ross PL, West DW. Comparison of methods for classifying Hispanic ethnicity in a population-based cancer registry. Am J Epidemiol. 1999;149:1063–71.
Gomez SL, Glaser SL. Misclassification of race/ethnicity in a population-based cancer registry (United States). Cancer Causes Control. 2006;17:771–81.
Clegg LX, Reichman ME, Hankey BF, et al. Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control. 2007;18:177–87.
Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics. 2003;164:1567–87.
Disclosure
There is no specific funding source for this work. There is no financial disclosure.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hashiguchi, Y., Hase, K., Ueno, H. et al. Impact of Race/Ethnicity on Prognosis in Patients Who Underwent Surgery for Colon Cancer: Analysis for White, African, and East Asian Americans. Ann Surg Oncol 19, 1517–1528 (2012). https://doi.org/10.1245/s10434-011-2113-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-011-2113-5